SEQUADERMA
LIVE

Serial Number

79171753

Owner

Pro Bono Bio Entrepreneur Limited

Attorney

Roberta S. Bren

Filing Date

Apr 20, 2015

Add to watchlist:

No watchlists yet
View on USPTO

SEQUADERMA Trademark

Serial Number: 79171753 • Registration: 5000628

SEQUADERMA is a trademark filed by Pro Bono Bio Entrepreneur Limited on April 20, 2015. The trademark is classified under Class 3 (Cosmetics & Cleaning), Class 5 (Pharmaceuticals), Class 10 (Medical Apparatus). The application is currently registered and active.

Owner Contact Info

Pro Bono Bio Entrepreneur Limited (10 trademarks)

4th floor,

Entity Type: 99

Trademark Details

Filing Date

April 20, 2015

Registration Date

July 19, 2016

Published for Opposition

May 3, 2016

Cancellation Date

April 20, 2025

Goods & Services

Non-medicated toiletries, non-medicated skin care preparations, face cleansers, non-medicated cosmetic preparations for skin care, beauty serums; beauty balms; non-medicated skin balms, skin toners, non-medicated exfoliating preparations for skin; gel eye masks, facial beauty masks; non-medicated skin creams, oils, lotions and sprays; non-medicated skin conditioners, skin moisturisers, eye cream, eye gel, lip moisturisers, lip balm, hand cream, body lotions, body wash, foot balms, body scrubs; essential oils, fragrances, soap, hair care preparations, dentifrices

Medical devices for topical use in the treatment of dermal conditions associated with all layers of the skin, superficial and deep, namely, medical devices in the nature of a carrier with nanostructures which cross through the skin, allowing subcutaneous adsorption for the treatment of conditions of the skin; molecular filtering devices for medical purposes, namely, a gel or cream preparation as a drug delivery device which filters through or migrates into the skin and has a physical therapeutic effect; medical, veterinary and surgical apparatus, instruments and devices, namely, a medical device in which vesicles act as a drug delivery device in the nature of non-pharmaceutical nanostructures that migrate through the skin and have a physical therapeutic effect; inhalers for medical purposes sold empty; injection apparatus, instruments and devices, namely, injection needles, injection instruments without needles; medical and surgical apparatus, instruments and devices for the administration of skin disease and aging therapy and prophylaxis preparations and substances

Pharmaceutical preparations and substances for the treatment of pain and inflammation and diseases and disorders of the skin, eczema, psoriasis, acne, aging and thinning skin, rosacea and dermatitis; veterinary preparations for the treatment of pain and inflammation and diseases and disorders of the skin, eczema, psoriasis, acne, aging and thinning skin, rosacea and dermatitis; sanitary preparations for medical use; chemical preparations for pharmaceutical or medical purposes, namely, for the treatment of pain and inflammation and diseases and disorders of the skin, eczema, psoriasis, acne, aging and thinning skin, rosacea and dermatitis; topical and parenteral preparations of vesicles in the nature of pharmaceutical or medical preparations for the treatment of pain and inflammation and diseases and disorders of the skin, eczema, psoriasis, acne, aging and thinning skin, rosacea and dermatitis; chemical preparations in the form of vesicles for medical and veterinary purposes for the treatment of pain and inflammation and diseases and disorders of the skin, eczema, psoriasis, acne, aging and thinning skin, rosacea and dermatitis; chemical membranes and chemical aggregates for medical and veterinary purposes for the treatment of pain and inflammation and diseases and disorders of the skin, eczema, psoriasis, acne, aging and thinning skin, rosacea and dermatitis; preparations of arachidonic acids for medical or pharmaceutical purposes; dispersions and dry preparations of liposomal active substances for use as a pharmaceutical, cosmetic and veterinary substance carrier; cosmeceutical preparations for medical use for the treatment of pain and inflammation and diseases and disorders of the skin, eczema, psoriasis, acne, aging and thinning skin, rosacea and dermatitis; local anesthetics; lipids for topical and parenteral use for medical or pharmaceutical purposes; medical or pharmaceutical creams, dispersions, lotions, ointments, gels, solutions, sprays, lacquers, foams and film forming solution for the treatment of ocular conditions, subcutaneous conditions such as cellulitis, dermal conditions associated with all layers of the skin, superficial and deep; medical or pharmaceutical surfactants for use in the treatment of diseases affecting the immune system, inflammatory diseases, diseases of the skin, hair and ear, the treatment of pain and inflammation, rosacea and skin redness, atopic eczema, dishydrotic hand eczema, seborrhoeic eczema, pruritus and other skin irritations, plaque type psoriasis, acne vulgaris, breakouts, spots and other blemishes, bacterial, fungal and viral infections related to the skin and/or its secretions, male pattern baldness, the treatment of wrinkles, eye-bags, pigmentation disorders and other dermatological conditions caused by skin aging and other forms of damage or where skin supporting structures become weakened

Filing History

NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG E-MAILED
Feb 12, 2026 DENA
DEATH OF INTERNATIONAL REGISTRATION
Feb 12, 2026 DETH
NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG E-MAILED
Nov 15, 2025 DENA
DEATH OF INTERNATIONAL REGISTRATION
Nov 15, 2025 DETH
TOTAL INVALIDATION PROCESSED BY THE IB
Oct 31, 2023 INNT
TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
Oct 7, 2023 INTS
INVALIDATION PROCESSED
Oct 7, 2023 INPC
TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
Oct 3, 2023 INTR
CANCELLED SECTION 71
Feb 3, 2023 C71T
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Jul 19, 2021 REM3
NEW REPRESENTATIVE AT IB RECEIVED
Jan 3, 2020 NREP
NEW REPRESENTATIVE AT IB RECEIVED
Aug 9, 2019 NREP
FINAL DECISION TRANSACTION PROCESSED BY IB
Dec 23, 2016 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Dec 6, 2016 FICS
FINAL DISPOSITION PROCESSED
Dec 6, 2016 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Oct 19, 2016 FICR
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Jul 28, 2016 OPNX
REGISTERED-PRINCIPAL REGISTER
Jul 19, 2016 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
May 3, 2016 NPUB
PUBLISHED FOR OPPOSITION
May 3, 2016 PUBO
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Apr 20, 2016 OPNS
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Apr 20, 2016 OP2R
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Apr 13, 2016 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Mar 31, 2016 CNSA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Mar 15, 2016 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Mar 15, 2016 REAP
TEAS/EMAIL CORRESPONDENCE ENTERED
Mar 15, 2016 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Mar 15, 2016 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Mar 15, 2016 TROA
REFUSAL PROCESSED BY IB
Oct 2, 2015 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Sep 16, 2015 RFCS
REFUSAL PROCESSED BY MPU
Sep 16, 2015 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Sep 16, 2015 RFCR
NON-FINAL ACTION WRITTEN
Sep 15, 2015 CNRT
APPLICATION FILING RECEIPT MAILED
Sep 12, 2015 MAFR
ASSIGNED TO EXAMINER
Sep 8, 2015 DOCK
ASSIGNED TO EXAMINER
Sep 8, 2015 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Sep 8, 2015 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Sep 3, 2015 REPR